tiprankstipranks
Trending News
More News >
Cytek Biosciences (CTKB)
NASDAQ:CTKB

Cytek Biosciences (CTKB) Revenue

Compare
58 Followers

Cytek Biosciences Revenue

Cytek Biosciences had a revenue of 41.46M in the quarter ending Mar 31, 2025, with -27.87%. This bring the company's revenue in the last twelve months to 197.05M, Increased -1.70%. In the fiscal year ending Dec 31, 2024, Cytek Biosciences had annual revenue of 200.45M with 3.85% growth.
Revenue (ttm)
197.05M
Revenue Growth
-1.86%
P/S Ratio
2.15
Revenue/Employee
$302,342
Employees
663
Market Cap
$430.64M

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2024
200.45M7.44M+3.85%
Dec 31, 2023
193.01M28.98M+17.67%
Dec 31, 2022
164.04M36.09M+28.20%
Dec 31, 2021
127.95M35.11M+37.82%
Dec 31, 2020
92.84M34.96M+60.39%
Dec 31, 2019
57.88M
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis